The ratio of antiangiogenic VEGF 165 b to total VEGF in platelet supernatants was higher in patients with SSc than in control subjects, but the difference did not reach statistical significance ( n = 12; p = 0.071, t test) (Fig. 2b ).
1
0.0710
0.0710